PL435319A1 - Sposób otrzymywania hialuronidazy oraz produkt otrzymany tym sposobem - Google Patents

Sposób otrzymywania hialuronidazy oraz produkt otrzymany tym sposobem

Info

Publication number
PL435319A1
PL435319A1 PL435319A PL43531920A PL435319A1 PL 435319 A1 PL435319 A1 PL 435319A1 PL 435319 A PL435319 A PL 435319A PL 43531920 A PL43531920 A PL 43531920A PL 435319 A1 PL435319 A1 PL 435319A1
Authority
PL
Poland
Prior art keywords
product obtained
concentration
filtration
ballast
ultrafiltration
Prior art date
Application number
PL435319A
Other languages
English (en)
Other versions
PL244350B1 (pl
Inventor
Monika BESMAN
Magdalena MATWIEJCZYK
Grzegorz CIURA
Filip Porzucek
Konrad BABIJ
Michał ŁOBOCKI
Original Assignee
Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością filed Critical Pharmfactor Spółka Z Ograniczoną Odpowiedzialnością
Priority to PL435319A priority Critical patent/PL244350B1/pl
Priority to EP21810152.5A priority patent/EP4240838A1/en
Priority to PCT/PL2021/050066 priority patent/WO2022060235A1/en
Publication of PL435319A1 publication Critical patent/PL435319A1/pl
Publication of PL244350B1 publication Critical patent/PL244350B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2474—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/10—Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/12—Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to the preparation of the feed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34—Size selective separation, e.g. size exclusion chromatography, gel filtration, permeation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361—Ion-exchange
    • B01D15/362—Cation-exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • B01D61/146—Ultrafiltration comprising multiple ultrafiltration steps
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01035—Hyaluronoglucosaminidase (3.2.1.35), i.e. hyaluronidase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/04—Specific process operations in the feed stream; Feed pretreatment
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/06—Specific process operations in the permeate stream
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/12—Addition of chemical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2623—Ion-Exchange
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2676—Centrifugal separation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D2311/00—Details relating to membrane separation process operations and control
    • B01D2311/26—Further operations combined with membrane separation processes
    • B01D2311/2697—Chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Przedmiotem wynalazku jest sposób otrzymywania hialuronidazy zawierający kolejno etapy: rozdrobnienie tkanki, ekstrakcja, precypitacja balastów, filtracja, zatężanie I, inkubacja, ultrafiltracja I, zatężanie II, wysalanie balastów, wirowanie, chromatografia I sączenie żelowe, chromatografia II cieczowa jonowymienna, ultrafiltracja II, zatężanie III, filtracja wyjaławiająca i suszenie. Przedmiotem wynalazku jest również produkt otrzymany tym sposobem.
PL435319A 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem PL244350B1 (pl)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem
EP21810152.5A EP4240838A1 (en) 2020-09-15 2021-09-14 Method of obtaining hyaluronidase from bovine testes
PCT/PL2021/050066 WO2022060235A1 (en) 2020-09-15 2021-09-14 Method of obtaining hyaluronidase from bovine testes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem

Publications (2)

Publication Number Publication Date
PL435319A1 true PL435319A1 (pl) 2022-03-21
PL244350B1 PL244350B1 (pl) 2024-01-15

Family

ID=78650030

Family Applications (1)

Application Number Title Priority Date Filing Date
PL435319A PL244350B1 (pl) 2020-09-15 2020-09-15 Sposób otrzymywania hialuronidazy ze zwierzęcych jąder oraz produkt otrzymany tym sposobem

Country Status (3)

Country Link
EP (1) EP4240838A1 (pl)
PL (1) PL244350B1 (pl)
WO (1) WO2022060235A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102528707B1 (ko) * 2022-11-01 2023-05-04 한국코러스 주식회사 고순도의 히알루로니다제 정제 방법
CN117165558B (zh) * 2023-09-27 2024-07-09 四川德博尔制药有限公司 一种透明质酸酶的制备方法
CN117723682B (zh) * 2023-11-20 2024-06-11 山东丰金美业科技有限公司 一种交联透明质酸或其盐凝胶交联度的检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2027759C1 (ru) * 1992-02-03 1995-01-27 Пак Владимир Николаевич Способ получения гиалуронидазы

Also Published As

Publication number Publication date
EP4240838A1 (en) 2023-09-13
PL244350B1 (pl) 2024-01-15
WO2022060235A1 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
PL435319A1 (pl) Sposób otrzymywania hialuronidazy oraz produkt otrzymany tym sposobem
EA200602191A1 (ru) 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
EA200801372A1 (ru) Способы получения замещенных пиримидинов
MX2019010848A (es) Composiciones y procedimientos para el tratamiento del cancer.
MA34710B1 (fr) Procede de traitement des troubles associes au fgf21
DOP2011000045A (es) Anticuerpos monoclonales contra el inhibidor de la via del factor tisular (tfpi)
DE602005026143D1 (de) Erkennung eines erhöhten spiegels von her-2/neu-proteinen in zirkulierenden krebszellen und dessen behandlung
EA201290139A1 (ru) Модуляторы кальциевого канала, активируемого высвобождением кальция, представляющие собой производные пиразола, и способы лечения немелкоклеточного рака легких
EA200700852A1 (ru) Новый способ получения пищевых продуктов
EA201070930A1 (ru) Способ получения чайного продукта
AR050796A1 (es) Procedimiento de produccion del polisacarido k5
MX2020012107A (es) Composiciones y procedimientos para el tratamiento del cancer.
BR112023002455A2 (pt) Anticorpos fgfr3 e métodos de uso
NZ599442A (en) Allergy treatment using acid treated aqueous whey protein extract
AU2017373587A1 (en) Method for producing transparent preparations for examination by light microscopy
EP1638505A4 (en) AMPHIPHILI PYRIDINIUM COMPOUNDS, METHOD OF MANUFACTURE AND ITS USE
ATE432930T1 (de) Benzosulfonamide derivate, deren verfahren zum herstellung, und deren verwendung zur behandlung von schmerzen
DE60124526D1 (de) Methode zur identifizierung von helicobacter antigenen
BR112022023697A2 (pt) Métodos e meios para a produção de moléculas semelhantes a ig
MX2022011880A (es) Composiciones y metodos para tratar distrofia muscular.
PH12019502442A1 (en) Variants of human bmp7 protein
DE602005027228D1 (de) Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
WO2023082523A1 (zh) 一种提高罗非鱼头骨制备硫酸软骨素提取率的方法
FR2893504B1 (fr) Procede d'obtention d'un principe actif exhausteur de la resistance mecanique cutanee, principe actif et compositions
ATE488137T1 (de) Zusammensetzung für die behandlung von bakteriellen erkrankungen, viruserkrankungen, pilzlichen erkrankungen, entzündungen und schmerzen